First randomized evaluation of safety, pharmacodynamics, and pharmacokinetics of BAY 1831865, an antibody targeting coagulation factor XI and factor XIa, in healthy men.


First published in Journal of Thrombosis and Haemostasis on 2022 May.
J Thromb Haemost. 2022 May 1. doi: 10.1111/jth.15744. Online ahead of print.

Authors: Nowotny B, Thomas D, Schwers S, Wiegmann S, Prange W, Yassen A, Boxnick S





Read more

Download full article as Pdf file:

Pdf File